ArticleScientific reports2019

Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants.

Puay-Wah Phuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.